| | | (6) The extent to which insurance coverage of the | | health care service or provider may be reasonably | | expected to increase or decrease the insurance premium | | and administrative expenses of policyholders; |
|
| | | (7) The impact of indirect costs, which are costs | | other than premiums and administrative costs, on the | | question of the costs and benefits of coverage; |
|
| | | (8) The impact of this coverage on the total cost of | | health care, including potential benefits and savings | | to insurers and employers because the proposed mandated | | treatment or service prevents disease or illness or | | leads to the early detection and treatment of disease | | or illness that is less costly than treatment or | | service for later stages of a disease or illness; |
|
| | | (9) The effects of mandating the benefit on the cost | | of health care, particularly the premium and | | administrative expenses and indirect costs, to | | employers and employees, including the financial impact | | on small employers, medium-sized employers and large | | employers; and |
|
| | | (10) The effect of the proposed mandate on cost- | | shifting between private and public payors of health | | care coverage and on the overall cost of the health | care delivery system in this State;. |
|
| | | In order to enable the committee to assess the financial | | impact of the benefit, the report must include a comparison | | of the rate of increase in the Consumer Price Index for | | medical care services to the rate of increase in the | | Consumer Price Index for the previous year and the current | | year as reported by the United States Department of Labor, | | Bureau of Labor Statistics; |
|
|